Form 8-K - Current report:
SEC Accession No. 0001213900-25-003886
Filing Date
2025-01-15
Accepted
2025-01-15 16:52:36
Documents
13
Period of Report
2025-01-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227757-8k_osthera.htm   iXBRL 8-K 27855
  Complete submission text file 0001213900-25-003886.txt   203065

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ostx-20250114.xsd EX-101.SCH 3024
3 XBRL LABEL FILE ostx-20250114_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ostx-20250114_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0227757-8k_osthera_htm.xml XML 3811
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 25533465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)